OIS at AAO 2015

Transcend Medical

Nov 12, 2015 9:10am ‐ Nov 12, 2015 9:18am


Transcend Medical is focused on the development of technologies to transform the treatment of glaucoma, the leading cause of adult irreversible blindness. Our flagship product, the CyPass® Micro-Stent, is a next-generation, minimally invasive device designed to enhance aqueous outflow to the suprachoroidal space, part of the eye’s natural drainage systems.


  • Sean Ianchulev, MD, MPH, CMO & VP, Medical Affairs & Business Development, Transcend Medical

You must be logged in and own this session in order to post comments.